StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$1.98+0.04 (+2.06%)

Close on Nov 12, 2026Market cap $78.11MP/E –Yield –

Sera Prognostics operating margin

Operating margin is operating income as a percentage of revenue.

Sera Prognostics's operating margin for the twelve months ending Sep 30, 2026 was -38755.2%. For fiscal 2025 it was -45066.7%, against -47577.9% the year before. The highest annual figure on record is -13013.4% in fiscal 2023.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-45066.7%+2511.3
FY2024Dec 31, 2024-47577.9%−34564.5
FY2023Dec 31, 2023-13013.4%+4020.9
FY2022Dec 31, 2022-17034.3%+26130.3
FY2021Dec 31, 2021-43164.6%+28719.4
FY2020Dec 31, 2020-71884.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-21159.5%+34965.5
Q2 FY2026Jun 30, 2026-33346.7%+21476.9
Q1 FY2026Mar 31, 2026-66857.1%−42515.0
Q4 FY2025Dec 31, 2025-89540.0%−50277.5
Q3 FY2025Sep 30, 2025-56125.0%−25566.4
Q2 FY2025Jun 30, 2025-54823.5%−16269.4
Q1 FY2025Mar 31, 2025-24342.1%−2761.6
Q4 FY2024Dec 31, 2024-39262.5%−19776.8
Q3 FY2024Sep 30, 2024-30558.6%−21241.5
Q2 FY2024Jun 30, 2024-38554.2%−27225.2
Q4 FY2023Dec 31, 2023-21580.5%−5552.8
Q3 FY2023Sep 30, 2023-19485.7%−6625.9
Q2 FY2023Jun 30, 2023-9317.1%+5741.9
Q1 FY2023Mar 31, 2023-11329.0%+21039.4
Q4 FY2022Dec 31, 2022-16027.7%+32230.0
Q3 FY2022Sep 30, 2022-12859.8%+28192.4
Q2 FY2022Jun 30, 2022-15059.0%+21846.0
Q1 FY2022Mar 31, 2022-32368.4%+13977.7
Q4 FY2021Dec 31, 2021-48257.7%+30975.6
Q3 FY2021Sep 30, 2021-41052.2%+51827.8
Q2 FY2021Jun 30, 2021-36905.0%+34445.0
Q1 FY2021Mar 31, 2021-46346.2%–
Q4 FY2020Dec 31, 2020-79233.3%–
Q3 FY2020Sep 30, 2020-92880.0%–
Q2 FY2020Jun 30, 2020-71350.0%–

More Sera Prognostics figures

See a number that looks wrong?